Aspect Partners’s Thermo Fisher Scientific TMO Stock Holding History

Aspect Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$205K	Buy	303 +1	+0.3%	+$594	0.08%	82
2026 Q2	$151K	Hold	302	–	–	0.06%	92
2026 Q1	$148K	Sell	302 -1	-0.3%	-$543	0.06%	89
2025 Q4	$176K	Buy	303 +1	+0.3%	+$566	0.08%	84
2025 Q3	$146K	Hold	302	–	–	0.07%	90
2025 Q2	$122K	Sell	302 -1	-0.3%	-$418	0.06%	99
2025 Q1	$151K	Sell	303 -1	-0.3%	-$542	0.09%	81
2024 Q4	$158K	Hold	304	–	–	0.09%	79
2024 Q3	$188K	Hold	304	–	–	0.11%	68
2024 Q2	$168K	Sell	304 -155	-34%	-$88.8K	0.1%	77
2024 Q1	$267K	Hold	459	–	–	0.21%	60
2023 Q4	$244K	Buy	+459	New	+$222K	0.16%	60

Other funds holding TMO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Aspect Partners's TMO Position: Q3 2026 in Review

Aspect Partners increased its Thermo Fisher Scientific (TMO) stake by 0.33% in Q3 2026, buying an estimated $594 and bringing the position to 303 shares worth $205K. The position accounts for 0.08% of the portfolio, ranked #82.

Aspect Partners first reported a position in TMO in Q4 2023 and has held it in 12 quarters since. The position peaked at $267K in Q1 2024. 1,615 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Aspect Partners held 303 shares of Thermo Fisher Scientific worth $205K as of Q3 2026.
Aspect Partners bought 1 Thermo Fisher Scientific share in Q3 2026, an estimated $594.
Thermo Fisher Scientific made up 0.08% of Aspect Partners's portfolio in Q3 2026, its #82 holding.
Aspect Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 12 quarters since.
Aspect Partners's Thermo Fisher Scientific position peaked at $267K in Q1 2024.
1,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.